In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Background Drug-eluting stents (DES) have substantially reduced the incidence of coronary in-stent restenosis (ISR), but the problem persists. Clinical presentation and outcomes of DES-ISR in a real-world scenario remains underreported.